Crystalloid solutions

Donald Prough, Joel Olsson, Christer Svensén

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Crystalloid (salt) solutions are the cornerstone of clinical volume replacement, either during surgery or to treat traumatic blood loss. In contrast to blood transfusion, crystalloids are distributed significantly in the extravascular spaces, and the rates of distribution after infusion are not easily predictable. This chapter presents a theoretical basis for this phenomenon and explains why adequate replacement of blood losses with crystalloid requires infusion of between three and seven times the volume of loss. Infusion of large volumes can have undesired consequences, such as hypercoagulation, acidosis and tissue edema, particularly in the lung and gastrointestinal tract. It is important to understand the physiologic changes that follow infusion of these solutions. Furthermore, when blood substitutes are available, they will be used in combination with crystalloids. Although the overall safety of crystalloid fluids for blood replacement and perioperative fluid management appears to be outstanding, there remain several areas in which further information is necessary. The kinetics of crystalloids may favor interstitial accumulation during perioperative administration, and may be associated with postoperative complications in certain types of surgery such as bowel surgery. The effects of specific crystalloids on immune function, metabolic status and coagulation are potentially important and require continued study.

Original languageEnglish (US)
Title of host publicationBlood Substitutes
PublisherElsevier Ltd
Pages126-138
Number of pages13
ISBN (Print)9780127597607
DOIs
StatePublished - 2006

Fingerprint

Blood
Surgery
Blood Substitutes
Fluids
Acidosis
crystalloid solutions
Coagulation
Blood Transfusion
Gastrointestinal Tract
Edema
Salts
Tissue
Safety
Lung
Kinetics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Prough, D., Olsson, J., & Svensén, C. (2006). Crystalloid solutions. In Blood Substitutes (pp. 126-138). Elsevier Ltd. https://doi.org/10.1016/B978-012759760-7/50018-4

Crystalloid solutions. / Prough, Donald; Olsson, Joel; Svensén, Christer.

Blood Substitutes. Elsevier Ltd, 2006. p. 126-138.

Research output: Chapter in Book/Report/Conference proceedingChapter

Prough, D, Olsson, J & Svensén, C 2006, Crystalloid solutions. in Blood Substitutes. Elsevier Ltd, pp. 126-138. https://doi.org/10.1016/B978-012759760-7/50018-4
Prough D, Olsson J, Svensén C. Crystalloid solutions. In Blood Substitutes. Elsevier Ltd. 2006. p. 126-138 https://doi.org/10.1016/B978-012759760-7/50018-4
Prough, Donald ; Olsson, Joel ; Svensén, Christer. / Crystalloid solutions. Blood Substitutes. Elsevier Ltd, 2006. pp. 126-138
@inbook{1ff8fd56038c440d8ef3ed28ffa12abb,
title = "Crystalloid solutions",
abstract = "Crystalloid (salt) solutions are the cornerstone of clinical volume replacement, either during surgery or to treat traumatic blood loss. In contrast to blood transfusion, crystalloids are distributed significantly in the extravascular spaces, and the rates of distribution after infusion are not easily predictable. This chapter presents a theoretical basis for this phenomenon and explains why adequate replacement of blood losses with crystalloid requires infusion of between three and seven times the volume of loss. Infusion of large volumes can have undesired consequences, such as hypercoagulation, acidosis and tissue edema, particularly in the lung and gastrointestinal tract. It is important to understand the physiologic changes that follow infusion of these solutions. Furthermore, when blood substitutes are available, they will be used in combination with crystalloids. Although the overall safety of crystalloid fluids for blood replacement and perioperative fluid management appears to be outstanding, there remain several areas in which further information is necessary. The kinetics of crystalloids may favor interstitial accumulation during perioperative administration, and may be associated with postoperative complications in certain types of surgery such as bowel surgery. The effects of specific crystalloids on immune function, metabolic status and coagulation are potentially important and require continued study.",
author = "Donald Prough and Joel Olsson and Christer Svens{\'e}n",
year = "2006",
doi = "10.1016/B978-012759760-7/50018-4",
language = "English (US)",
isbn = "9780127597607",
pages = "126--138",
booktitle = "Blood Substitutes",
publisher = "Elsevier Ltd",

}

TY - CHAP

T1 - Crystalloid solutions

AU - Prough, Donald

AU - Olsson, Joel

AU - Svensén, Christer

PY - 2006

Y1 - 2006

N2 - Crystalloid (salt) solutions are the cornerstone of clinical volume replacement, either during surgery or to treat traumatic blood loss. In contrast to blood transfusion, crystalloids are distributed significantly in the extravascular spaces, and the rates of distribution after infusion are not easily predictable. This chapter presents a theoretical basis for this phenomenon and explains why adequate replacement of blood losses with crystalloid requires infusion of between three and seven times the volume of loss. Infusion of large volumes can have undesired consequences, such as hypercoagulation, acidosis and tissue edema, particularly in the lung and gastrointestinal tract. It is important to understand the physiologic changes that follow infusion of these solutions. Furthermore, when blood substitutes are available, they will be used in combination with crystalloids. Although the overall safety of crystalloid fluids for blood replacement and perioperative fluid management appears to be outstanding, there remain several areas in which further information is necessary. The kinetics of crystalloids may favor interstitial accumulation during perioperative administration, and may be associated with postoperative complications in certain types of surgery such as bowel surgery. The effects of specific crystalloids on immune function, metabolic status and coagulation are potentially important and require continued study.

AB - Crystalloid (salt) solutions are the cornerstone of clinical volume replacement, either during surgery or to treat traumatic blood loss. In contrast to blood transfusion, crystalloids are distributed significantly in the extravascular spaces, and the rates of distribution after infusion are not easily predictable. This chapter presents a theoretical basis for this phenomenon and explains why adequate replacement of blood losses with crystalloid requires infusion of between three and seven times the volume of loss. Infusion of large volumes can have undesired consequences, such as hypercoagulation, acidosis and tissue edema, particularly in the lung and gastrointestinal tract. It is important to understand the physiologic changes that follow infusion of these solutions. Furthermore, when blood substitutes are available, they will be used in combination with crystalloids. Although the overall safety of crystalloid fluids for blood replacement and perioperative fluid management appears to be outstanding, there remain several areas in which further information is necessary. The kinetics of crystalloids may favor interstitial accumulation during perioperative administration, and may be associated with postoperative complications in certain types of surgery such as bowel surgery. The effects of specific crystalloids on immune function, metabolic status and coagulation are potentially important and require continued study.

UR - http://www.scopus.com/inward/record.url?scp=84882510078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882510078&partnerID=8YFLogxK

U2 - 10.1016/B978-012759760-7/50018-4

DO - 10.1016/B978-012759760-7/50018-4

M3 - Chapter

SN - 9780127597607

SP - 126

EP - 138

BT - Blood Substitutes

PB - Elsevier Ltd

ER -